Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 7, ...
For the full list of side effects and restrictions with Jemperli, see the package leaflet. The most common side effects with Jemperli used alone (which may affect more than 1 in 10 people) include anaemia (low count of red blood cells), diarrhoea, nausea ( …